Search - tctmd.com

Displaying 81 - 100 of 194

Sort: Relevancy | Date

News Daily News

Everyone’s Glum About RECOVER IV: Where Shock Care Heads Next Is Unclear

Caitlin E. Cox

July 03, 2024

News Features

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Caitlin E. Cox

May 02, 2024

News Conference News ACC 2024

Long-Awaited RCT Data Show Survival Benefit With Impella CP: DanGer Shock

Caitlin E. Cox

April 07, 2024

News Daily News

Abiomed Recalls Labeling for Left-Sided Impella Pumps: FDA

Caitlin E. Cox

March 21, 2024

News Conference News CRT 2024

SAFE-MCS: Monitoring System Intercepts Bleeding in High-risk PCI

L.A. McKeown

March 15, 2024

Presentation THT 2024

Shock-Phenotype Matching Using Real-World Evidence: A New Paradigm for Prospective Enrollment in Clinical Trials of Acute MCS Devices in Cardiogenic Shock

Presenter: James W. Schurr

March 06, 2024

Presentation THT 2024

Contemporary Management of High-Risk PE: Focus on Temporary MCS Therapies and Surgical Thrombectomy

Presenter: Candice Lee

March 06, 2024

Presentation THT 2024

Continue MCS for Another 14 days

Presenter: Manreet Kanwar

March 04, 2024

Presentation THT 2024

A Challenging TAVR Case: Severe AS and Severe LV Dysfunction (Role of GDMT and MCS)

Presenter: Shmuel Chen

March 04, 2024

News Opinion CV Team Dispatch

March 2024 Dispatch for the CV Team

L.A. McKeown

March 01, 2024

News Daily News

New Risk Score Better for Capturing Medical Urgency for Heart Transplantation

Michael O'Riordan

February 19, 2024

Presentation Cardiovascular Interventions 2023

MCS: Choosing the Right Device For the Right Patient

Presenter: Amir Kaki

November 10, 2023

Presentation TCT 2023

State-of-the-art Lecture on Evidence for MCS in Cardiogenic Shock

Presenter: Holger Thiele

October 26, 2023

Presentation TCT 2023

Optimal Antithrombotic Strategies in MCS Use

Presenter: Mirvat Alasnag

October 26, 2023

Presentation TCT 2023

Con: Favorable Data Is Lacking on MCS in AMI Cardiogenic Shock (Randomized Data Are Needed)

Presenter: Sanjit Jolly

October 24, 2023

Presentation TCT 2023

Pro: Most Patients With AMI Cardiogenic Shock Should Get MCS (Randomization Is Unethical)

Presenter: William O'Neill

October 24, 2023

Presentation TCT 2023

TCT 740: Multidisciplinary Team Approach to Reducing Vascular Complications in MCS Impella Support Patients

Presenter: Haroon Faraz

October 24, 2023

Presentation TCT 2023

My Top 5 Most Critical Clinical and Technology Needs in Temporary MCS

Presenter: Nicolas Van Mieghem

October 23, 2023

News Daily News

Medicare Data on AMICS Too Muddied for Firm Conclusions on Impella

Caitlin E. Cox

June 21, 2023

Presentation Complex Coronary Cases 2023

Practical Application of New BifurcAID, STEMIcathAID, and MCSAID Apps

Presenter: Annapoorna S. Kini

June 16, 2023

Advertisement

Everyone’s Glum About RECOVER IV: Where Shock Care Heads Next Is Unclear

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Long-Awaited RCT Data Show Survival Benefit With Impella CP: DanGer Shock

Abiomed Recalls Labeling for Left-Sided Impella Pumps: FDA

SAFE-MCS: Monitoring System Intercepts Bleeding in High-risk PCI

Shock-Phenotype Matching Using Real-World Evidence: A New Paradigm for Prospective Enrollment in Clinical Trials of Acute MCS Devices in Cardiogenic Shock

Contemporary Management of High-Risk PE: Focus on Temporary MCS Therapies and Surgical Thrombectomy

Continue MCS for Another 14 days

A Challenging TAVR Case: Severe AS and Severe LV Dysfunction (Role of GDMT and MCS)

March 2024 Dispatch for the CV Team

New Risk Score Better for Capturing Medical Urgency for Heart Transplantation

MCS: Choosing the Right Device For the Right Patient

State-of-the-art Lecture on Evidence for MCS in Cardiogenic Shock

Optimal Antithrombotic Strategies in MCS Use

Con: Favorable Data Is Lacking on MCS in AMI Cardiogenic Shock (Randomized Data Are Needed)

Pro: Most Patients With AMI Cardiogenic Shock Should Get MCS (Randomization Is Unethical)

TCT 740: Multidisciplinary Team Approach to Reducing Vascular Complications in MCS Impella Support Patients

My Top 5 Most Critical Clinical and Technology Needs in Temporary MCS

Medicare Data on AMICS Too Muddied for Firm Conclusions on Impella

Practical Application of New BifurcAID, STEMIcathAID, and MCSAID Apps

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content